The World Health Organization (WHO) is creating an international training center to help poor countries develop vaccines, antibodies, and cancer treatments using Messenger RNA technology used to produce covad-19 vaccines.
Geneva – The World Health Organization (WHO) is creating an international training center to help poor countries develop vaccines, antibodies, and cancer treatment using Messenger RNA technology, which has been successfully used to develop covad-19 vaccines.
World Health Organization (WHO) Director-General Tewodros Adhanom Gebre-Jesus said in a press conference in Geneva on Wednesday that the new center will be in South Korea and that scientists and partners in South Africa are working on mRNA technology in South Africa. Vaccination by Moderna Inc. This effort is being carried out without the help of Moderna.
“Vaccines have helped change the course of the CVD-19 epidemic, but this scientific victory has severely limited access to these life-saving tools,” Tedros said.
This is the first time that the World Health Organization (WHO) has supported such extraordinary efforts to reverse the commercialization of commercially available vaccines by focusing on the pharmaceutical industry, which has given priority to developing countries from poor sales and manufacturing.
Both authorized MRI CVD-19 vaccine makers Moderna and Pfizer-BioNTech refused to share their vaccine formulation or technology knowledge with WHO and its partners.
The World Health Organization (WHO) estimates that the modernization of the Moderena vaccine may not be available until the end of next year or 2024, but that the timeline could be significantly shorter if the manufacturer agrees.
The global difference in covad-19 vaccines is huge. Africa currently produces only 1% of the world’s CVD-19 vaccine and only 11% of its population is vaccinated. In contrast, in a European country like Portugal, 84% of its population is fully vaccinated, and more than 59% of its population is vaccinated.
Last week, the World Health Organization (WHO) announced that six African countries – Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia – will have access to MRI covide-19 vaccines and technology. Tewodros said on Wednesday that five more countries will receive support from South Africa, the United States, Bangladesh, Indonesia, Pakistan, Serbia and Vietnam.
Earlier this year, a Cape Town-based company, which tried to repeat Moderna Inc.’s COVID-19 shot, said it had successfully tested a candidate who was about to start a laboratory test.
Scientists trying to develop the Moderena vaccine are believed to have more information about the vaccine in public places and to make it a little easier to produce than Pfizer-BioNTech.
Zein Rizvi, director of public relations for the advocacy group, welcomed the news and said that the World Health Organization’s efforts to curb COV-19 would address the growing demand for the global MRI vaccine.
“The World Health Organization (WHO) is in stark contrast to the failures of Moderena and Pfizers of the World, who have accumulated so much technology. “WHO is developing a more open and transparent alternative course. But he still needs help.
Rizvi Biden asked the administration, in particular, to pressure international pharmaceutical companies to share their COVID-19 vaccine recipes and knowledge.
——
Follow the AP epidemic coverage at https://apnews.com/hub/coronavirus-pandemic
.